These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12432644)

  • 1. [Omeprazole. Antiulcer and gastric anti-secretory agent: one of the most prescribed drugs in France].
    Taeron C
    Rev Infirm; 2002 Oct; (84):49-50. PubMed ID: 12432644
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology and clinical effects of acid determination in ulcer hemorrhage].
    Schepp W
    Bildgebung; 1993 Apr; 60 Suppl 1():41-4. PubMed ID: 8104063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
    Bulgakov SA
    Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is gastric and duodenal ulcer drug-treatable or surgical disease?].
    Fedele E
    Chir Ital; 1997; 49(1-2):5-8. PubMed ID: 12743869
    [No Abstract]   [Full Text] [Related]  

  • 5. [The pharmacodynamics of the H+, K(+)-ATPase blocker omeprazole].
    Kukes VG; Sokolova TV; Petrov IN
    Eksp Klin Farmakol; 1993; 56(6):21-2. PubMed ID: 8111288
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiulcerogenic and ulcer healing effects of Solanum nigrum (L.) on experimental ulcer models: possible mechanism for the inhibition of acid formation.
    Jainu M; Devi CS
    J Ethnopharmacol; 2006 Mar; 104(1-2):156-63. PubMed ID: 16202548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of antiulcer effect of Neem (Azadirachta indica) leaf extract: effect on H+-K+-ATPase, oxidative damage and apoptosis.
    Chattopadhyay I; Nandi B; Chatterjee R; Biswas K; Bandyopadhyay U; Banerjee RK
    Inflammopharmacology; 2004; 12(2):153-76. PubMed ID: 15265317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
    McColl KE
    Dig Dis; 1988; 6(2):65-75. PubMed ID: 3129220
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gastrin-17 level in the omeprazole treatment of duodenal ulcer].
    Belov DF; Maksimova ID; Ponomarev AA; Loginov AF
    Eksp Klin Gastroenterol; 2005; (6):28-32, 112. PubMed ID: 17378383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Information on new drugs. 4. Drugs used for the treatment of gastric and duodenal ulcer].
    Ando Y
    Kango Gijutsu; 1986 Apr; 32(5):648-9. PubMed ID: 3636516
    [No Abstract]   [Full Text] [Related]  

  • 11. Proton pump inhibitors to be used more?
    Andrawiss M
    Drug Discov Today; 2005 May; 10(9):607-8. PubMed ID: 15894221
    [No Abstract]   [Full Text] [Related]  

  • 12. The anti-ulcer activities of bisabolangelone from Angelica polymorpha.
    Wang J; Zhu L; Zou K; Cheng F; Dan F; Guo Z; Cai Z; Yang J
    J Ethnopharmacol; 2009 Jun; 123(2):343-6. PubMed ID: 19429382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
    Isakov VA; Maev IV; Simanenkov VI; Kononov AV; Abdulkhakov RA; Zakharova NV; Livzan MA; Predvechnaia IK
    Ter Arkh; 2003; 75(11):71-3. PubMed ID: 14708448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of omeprazole on gastric bicarbonate secretion in patients with duodenal ulcer.
    Singh K; Nain CK; Singh V
    Indian J Gastroenterol; 1998; 17(4):136-7. PubMed ID: 9795500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of the medical therapy of gastric and duodenal ulcer].
    Barbara L; Corinaldesi R; Paternicò A; Stanghellini V
    Minerva Chir; 1987 Oct; 42(19):1449-55. PubMed ID: 3683903
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proton pump inhibitors].
    Schubert-Zsilavecz M; Stark H
    Pharm Unserer Zeit; 2005; 34(3):194-9. PubMed ID: 15940951
    [No Abstract]   [Full Text] [Related]  

  • 18. [Impact of Bestim on the immunological status and clinical course of ulcer].
    Tkacheva AG; Kalev OF; Dolgushina AI; Antipina TV
    Eksp Klin Gastroenterol; 2004; (6):29-33, 163. PubMed ID: 16259438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of anti-ulcer drugs on humoral immunity].
    Malov IuS
    Klin Med (Mosk); 1991 Oct; 69(10):71-4. PubMed ID: 1766224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric acid and salivary bicarbonate. Is there a relationship in duodenal ulcer patients?
    Namiot Z; Stasiewicz J; Markowski AR; Namiot DB; Jaroszewicz W; Kemona A; Górski J
    Rocz Akad Med Bialymst; 2004; 49():75-9. PubMed ID: 15631318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.